eLife (Jun 2019)

Glycolysis upregulation is neuroprotective as a compensatory mechanism in ALS

  • Ernesto Manzo,
  • Ileana Lorenzini,
  • Dianne Barrameda,
  • Abigail G O'Conner,
  • Jordan M Barrows,
  • Alexander Starr,
  • Tina Kovalik,
  • Benjamin E Rabichow,
  • Erik M Lehmkuhl,
  • Dakotah D Shreiner,
  • Archi Joardar,
  • Jean-Charles Liévens,
  • Robert Bowser,
  • Rita Sattler,
  • Daniela C Zarnescu

DOI
https://doi.org/10.7554/eLife.45114
Journal volume & issue
Vol. 8

Abstract

Read online

Amyotrophic Lateral Sclerosis (ALS), is a fatal neurodegenerative disorder, with TDP-43 inclusions as a major pathological hallmark. Using a Drosophila model of TDP-43 proteinopathy we found significant alterations in glucose metabolism including increased pyruvate, suggesting that modulating glycolysis may be neuroprotective. Indeed, a high sugar diet improves locomotor and lifespan defects caused by TDP-43 proteinopathy in motor neurons or glia, but not muscle, suggesting that metabolic dysregulation occurs in the nervous system. Overexpressing human glucose transporter GLUT-3 in motor neurons mitigates TDP-43 dependent defects in synaptic vesicle recycling and improves locomotion. Furthermore, PFK mRNA, a key indicator of glycolysis, is upregulated in flies and patient derived iPSC motor neurons with TDP-43 pathology. Surprisingly, PFK overexpression rescues TDP-43 induced locomotor deficits. These findings from multiple ALS models show that mechanistically, glycolysis is upregulated in degenerating motor neurons as a compensatory mechanism and suggest that increased glucose availability is protective.

Keywords